GINKGO BIOWORKS HOLDINGS, INC. Equity Securities, FV-NI and without Readily Determinable Fair Value
GINKGO BIOWORKS HOLDINGS, INC. (DNA) had Equity Securities, FV-NI and without Readily Determinable Fair Value of $14.78 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities › Equity Securities, FV-NI and without Readily Determinable Fair Value
us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue · last filed 2026-08-06
- 2026-06-30: Equity Securities, FV-NI and without Readily Determinable Fair Value $14.78M.
- 2026-03-31: Equity Securities, FV-NI and without Readily Determinable Fair Value $14.70M.
- 2025-12-31: Equity Securities, FV-NI and without Readily Determinable Fair Value $15.07M.
- 2025-09-30: Equity Securities, FV-NI and without Readily Determinable Fair Value $30.18M.
| Period end | Equity Securities, FV-NI and without Readily Determinable Fair Value |
|---|---|
| 2026-06-30 | $14.78M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $14.70M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $15.07M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $30.18M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $32.66M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $32.17M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $48.70M 10-K · filed 2026-02-26 |
| 2024-09-30 | $62.10M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $62.49M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $76.02M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $78.56M 10-K · filed 2025-02-25 |
| 2023-09-30 | $84.97M 10-Q · filed 2023-11-08 |
| 2022-12-31 | $112.19M 10-K · filed 2024-02-29 |